大豆皂苷II
| 中文名称 | 大豆皂苷II |
|---|---|
| 中文同义词 | 大豆皂苷II;大豆皂苷BC,大豆皂苷II |
| 英文名称 | (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8aR,9S,12aR,14aS,14bR)-9-hydro xy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8 ,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5S)-4,5 -dihydroxy-3-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy -oxan-2-yl]oxy-3,4-dihydroxy-oxane-2-carboxylic acid |
| 英文同义词 | (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8aR,9S,12aR,14aS,14bR)-9-hydro xy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8 ,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5S)-4,5 -dihydroxy-3-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy -oxan-2-yl]oxy-3,4-dihydroxy-oxane-2-carboxylic acid;(4S)-3β-[2-O-[2-O-(α-L-Rhamnopyranosyl)-α-L-arabinopyranosyl]-β-D-glucurono pyranosyloxy]oleana-12-ene-22β,24-diol;[(4S)-22β,23-Dihydroxyolean-12-en-3β-yl]2-O-[2-O-(6-deoxy-α-L-mannopyranosyl)-α-L-arabinopyranosyl]-β-D-glucopyranosiduronic acid;Soybean saponin Bc;β-D-Glucopyranosiduronic acid, (3β,4β,22β)-22,23-dihydroxyolean-12-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-α-L-arabinopyranosyl-(1→2)-;Soysaponin II;3-O-[α-L-rhamnopyranosyl(1->2)-α-L-arabinopyranosyl-(1->2)-β-D-glucuronopyranosyl]soyasaponin B;Soyasaponin II(Soyasaponin Bc,Soyasaponin B-II,Soysaponin II) |
| CAS号 | 55319-36-3 |
| 分子式 | C47H76O17 |
| 分子量 | 913.1 |
| EINECS号 | |
| 植物来源 | 大豆 |
| 相关类别 | 中药对照品;Miscellaneous Natural Products |
| Mol文件 | 55319-36-3.mol |
| 结构式 |  |
大豆皂苷II 性质
| 储存条件 | -20°C, protect from light |
|---|
Soyasaponin II 是具有抗病毒活性的皂苷。Soyasaponin II 抑制 HSV-1，HCMV，流感病毒和 HIV-1 的复制。Soyasaponin II 对 HSV-1 复制显示出有效的抑制作用。Soyasaponin II 作为 YB-1 磷酸化和 NLRP3 炎性小体引发的抑制剂，可保护小鼠免受 LPS/GalN 诱导的急性肝衰竭。
|
HSV-1 54 μM (IC 50 ) |
HIV-1 112 μM (IC 50 ) |
influenza virus 88 μM (IC 50 ) |
HCMV 104 μM (IC 50 ) |
NLRP3 inflammasome
|
Soyasaponin II inhibits the replication of HSV-1 (IC 50 =54μM), HCMV (104μM), influenza virus (88μM), and HIV-1 (112 μM).
Soyasaponin II (5 mg/kg; p.o.; once a day for three consecutive days) ameliorates canonical NLRP3 inflammasome-associated innate immune response.